Identification of a novel de novo gain-of-function mutation of PIK3CD in a patient with activated phosphoinositide 3-kinase δ syndrome
- 1 December 2018
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 197, 60-67
Abstract
No abstract availableKeywords
Funding Information
- National Health and Family Planning Commission of the People's Republic of China (201402012)
- Health and Family Planning Commission of Shenzhen Municipality (201506051)
- Shenzhen Municipal Government of China (JCYJ20160429174400950)
- Sanming Project of Medicine in Shenzen Municipality (SZSM201812002)
This publication has 30 references indexed in Scilit:
- Mammalian Target of Rapamycin Regulates IL-10 and Resistance to Pseudomonas aeruginosa Corneal InfectionThe Journal of Immunology, 2013
- Signaling by the Phosphoinositide 3-Kinase Family in Immune CellsAnnual Review of Immunology, 2013
- Canonical autophagy dependent on the class III phosphoinositide-3 kinase Vps34 is required for naive T-cell homeostasisProceedings of the National Academy of Sciences, 2012
- PI3K-Akt-mTORC1-S6K1/2 Axis Controls Th17 Differentiation by Regulating Gfi1 Expression and Nuclear Translocation of RORγCell Reports, 2012
- Dynamics of the Phosphoinositide 3-Kinase p110δ Interaction with p85α and Membranes Reveals Aspects of Regulation Distinct from p110αStructure, 2011
- PI3K p110δ regulates T-cell cytokine production during primary and secondary immune responses in mice and humansBlood, 2010
- The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα MutationsScience, 2007
- The PI3K p110δ controls T-cell development, differentiation and regulationBiochemical Society Transactions, 2007
- Role of the phosphoinositide 3‐kinase p110δ in generation of type 2 cytokine responses and allergic airway inflammationEuropean Journal of Immunology, 2007
- Mammalian Target of Rapamycin Pathway Blockade Slows Progression of Diabetic Kidney Disease in RatsJournal of the American Society of Nephrology, 2006